CYPRESS CAPITAL GROUP – Vertex Pharmaceuticals Incorporated Transaction History
CYPRESS CAPITAL GROUP portfolio value:
$377,000
portfolio value
CYPRESS CAPITAL GROUP quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +64.48% | 510 shares | 154K | $289.54 | 1.30K |
| Q2 2022 | share | 0.00% | 0 shares | 16K | $281.79 | 791 | |
| Q1 2022 | share | Decrease | -52.72% | -882 shares | -160K | $260.97 | 791 |
| Q4 2021 | share | Decrease | -49.85% | -1.66K shares | -238K | $222.45 | 1.67K |
| Q3 2021 | share | Decrease | -8.80% | -322 shares | -133K | $181.39 | 3.33K |
| Q2 2021 | share | Decrease | -15.07% | -649 shares | -188K | $201.63 | 3.65K |
| Q1 2021 | share | Decrease | -24.05% | -1.36K shares | -414K | $214.89 | 4.30K |
| Q4 2020 | share | Decrease | -23.69% | -1.76K shares | -683K | $236.34 | 5.67K |
| Q3 2020 | share | Increase | +34.52% | 1.90K shares | 419K | $272.12 | 7.43K |
| Q2 2020 | share | Increase | +476.72% | 4.56K shares | 1.37M | $290.31 | 5.52K |
| Q1 2020 | share | 0.00% | 0 shares | 18K | $237.95 | 958 | |
| Q4 2019 | share | Increase | 0.00% | 958 shares | 210K | $218.95 | 958 |